Warnings
Amphetamine (60.6%); Methanol (21.8%); Caffeine (17%); Ethylene glycol (0.6%) Valur previst Anfetamina. Rilevat Anfetamina 60.6%, Metanol 21.8%, Kaffeina 17%, Glikol tal-etilene 0.6%. Lokazzjoni: Vitoria-Gasteiz, Spanja. Data: 2026-06-01. Sors: ailaket.com.
Pillola Amphetamine (60.6%); Methanol (21.8%); Caffeine (17%); Ethylene glycol (0.6%) — Vitoria-Gasteiz, Spanja — 2026-06-01
Detected Amphetamine 60.6%, Methanol 21.8%, Caffeine 17%, Ethylene glycol 0.6%
Expected Amphetamine
Logo Unknown
Color Unknown
Location Vitoria-Gasteiz, Spain
Date 2026-06-01
Source ailaket.com
Media No image Detected Substances Amphetamine 60.6% Methanol 21.8% Caffeine 17% Ethylene glycol 0.6% Expected vs Detected Amphetamine
Detected result: Amphetamine 60.6%, Methanol 21.8%, Caffeine 17%, Ethylene glycol 0.6%
Sample Details No additional sample descriptors available.
Testing Context Location: Vitoria-Gasteiz, Spanja Date tested: 2026-06-01 Source: ailaket.com Harm Reduction Similar-looking pills can contain different substances or strengths. Use drug checking services when available. Start low and avoid assuming a logo identifies the contents. SampleDNA Beta 3494 avviżi relatati · Tagħrfu aktar dwar ammonzjonijiet komuni.
Amphetamine 60.6% Methanol 21.8% Caffeine 17% Ethylene glycol 0.6% Eżempji relatati u kombinazzjonijiet Amphetamine + Caffeine + Ethylene glycol 10 kampjuni
Identifikati flimkien f'riżi relatati tal-verifikazzjoni tad-droga.
Amphetamine + Caffeine + Ethanol + Methanol 1 kampjun
Identifikati flimkien f'riżi relatati tal-verifikazzjoni tad-droga.
Amphetamine + Caffeine + Ethylene glycol + Unknown 1 kampjun
Identifikati flimkien f'riżi relatati tal-verifikazzjoni tad-droga.
Amphetamine + Caffeine + Methanol + Unknown 1 kampjun
Identifikati flimkien f'riżi relatati tal-verifikazzjoni tad-droga.
Amphetamine + Ethylene glycol + Methanol 1 kampjun
Identifikati flimkien f'riżi relatati tal-verifikazzjoni tad-droga.
Esploratur DNA ta' kampjun
Links This static page is intended as the readable export baseline for crawler and low-capability delivery.